CliffBio
small molecule

CLINDAMYCIN HYDROCHLORIDE

CLINDAMYCIN HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyCosette Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameCLINDAMYCIN HYDROCHLORIDE
Active ingredientCLINDAMYCIN HYDROCHLORIDE
StrengthEQ 150MG BASE
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalSeptember 1989
Marketing statusDISCN

More from Cosette Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CLINDAMYCIN HYDROCHLORIDE patent cliff — loss of exclusivity — | CliffBio